Literature DB >> 33075810

HPV+ oropharyngeal squamous cell carcinomas from patients with two tumors display synchrony of viral genomes yet discordant mutational profiles and signatures.

Daniel L Faden1,2,3,4, Adam Langenbucher2, Krystle Kuhs5, James S Lewis6,7, Lisa Mirabello8, Meredith Yeager8,9, Joseph F Boland8,9, Sara Bass8,9, Mia Steinberg8,9, Michael Cullen8,9, Michael S Lawrence2,3,4, Robert L Ferris10,11,12.   

Abstract

Human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma (HPV + OPSCC) is increasing in prevalence in the USA, as are cases of patients with multiple HPV + OPSCCs (mHPV + OPSCC). mHPV + OPSCCs present a unique opportunity to examine HPV + OPSCC mutation acquisition and evolution. We performed sequencing of the viral genome, somatic exome and somatic transcriptome from 8 patients each with 2 spatially distinct HPV + OPSCCs, and 37 'traditional' HPV + OPSCCs to first address if paired tumors are caused by the same viral isolate and next, if acquired alterations, and the underlying processes driving mutagenesis, are shared within pairs. All tumor pairs contained viral genomes from the same HPV type 16 sublineage and differed by 0-2 clonal single nucleotide polymorphisms (SNPs), suggesting infection with the same viral isolate. Despite this, there was significant discordance in expression profiles, mutational burden and mutational profiles between tumors in a pair, with only two pairs sharing any overlapping mutations (3/3343 variants). Within tumor pairs there was a striking discrepancy of mutational signatures, exemplified by no paired tumors sharing high APOBEC mutational burden. Here, leveraging mHPV + OPSCCs as a model system to study mutation acquisition in virally mediated tumors, in which the germline, environmental exposures, immune surveillance and tissue/organ type were internally controlled, we demonstrate that despite infection by the same viral isolate, paired mHPV + OPSCCs develop drastically different somatic alterations and even more strikingly, appear to be driven by disparate underlying mutational processes. Thus, despite a common starting point, HPV + OPSCCs evolve through variable mutational processes with resultant stochastic mutational profiles.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2021        PMID: 33075810      PMCID: PMC8014522          DOI: 10.1093/carcin/bgaa111

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  23 in total

Review 1.  Human papillomavirus genome variants.

Authors:  Robert D Burk; Ariana Harari; Zigui Chen
Journal:  Virology       Date:  2013-08-31       Impact factor: 3.616

2.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

3.  The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.

Authors:  Farhoud Faraji; Eleni M Rettig; Hua-Ling Tsai; Margueritta El Asmar; Nicholas Fung; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2018-12-06       Impact factor: 6.860

4.  Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.

Authors:  Sumana Narayanan; Tsutomu Kawaguchi; Li Yan; Xuan Peng; Qianya Qi; Kazuaki Takabe
Journal:  Ann Surg Oncol       Date:  2018-05-16       Impact factor: 5.344

5.  HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.

Authors:  Lisa Mirabello; Meredith Yeager; Kai Yu; Gary M Clifford; Yanzi Xiao; Bin Zhu; Michael Cullen; Joseph F Boland; Nicolas Wentzensen; Chase W Nelson; Tina Raine-Bennett; Zigui Chen; Sara Bass; Lei Song; Qi Yang; Mia Steinberg; Laurie Burdett; Michael Dean; David Roberson; Jason Mitchell; Thomas Lorey; Silvia Franceschi; Philip E Castle; Joan Walker; Rosemary Zuna; Aimée R Kreimer; Daniel C Beachler; Allan Hildesheim; Paula Gonzalez; Carolina Porras; Robert D Burk; Mark Schiffman
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582

6.  Genomic heterogeneity of multiple synchronous lung cancer.

Authors:  Yu Liu; Jianjun Zhang; Lin Li; Guangliang Yin; Jianhua Zhang; Shan Zheng; Hannah Cheung; Ning Wu; Ning Lu; Xizeng Mao; Longhai Yang; Jiexin Zhang; Li Zhang; Sahil Seth; Huang Chen; Xingzhi Song; Kan Liu; Yongqiang Xie; Lina Zhou; Chuanduo Zhao; Naijun Han; Wenting Chen; Susu Zhang; Longyun Chen; Wenjun Cai; Lin Li; Miaozhong Shen; Ningzhi Xu; Shujun Cheng; Huanming Yang; J Jack Lee; Arlene Correa; Junya Fujimoto; Carmen Behrens; Chi-Wan Chow; William N William; John V Heymach; Waun Ki Hong; Stephen Swisher; Ignacio I Wistuba; Jun Wang; Dongmei Lin; Xiangyang Liu; P Andrew Futreal; Yanning Gao
Journal:  Nat Commun       Date:  2016-10-21       Impact factor: 14.919

7.  Human papillomavirus and the landscape of secondary genetic alterations in oral cancers.

Authors:  Maura L Gillison; Keiko Akagi; David E Symer; Weihong Xiao; Bo Jiang; Robert K L Pickard; Jingfeng Li; Benjamin J Swanson; Amit D Agrawal; Mark Zucker; Birgit Stache-Crain; Anne-Katrin Emde; Heather M Geiger; Nicolas Robine; Kevin R Coombes
Journal:  Genome Res       Date:  2018-12-18       Impact factor: 9.043

8.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

9.  Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection.

Authors:  Michael Cullen; Joseph F Boland; Mark Schiffman; Xijun Zhang; Nicolas Wentzensen; Qi Yang; Zigui Chen; Kai Yu; Jason Mitchell; David Roberson; Sara Bass; Laurie Burdette; Moara Machado; Sarangan Ravichandran; Brian Luke; Mitchell J Machiela; Mark Andersen; Matt Osentoski; Michael Laptewicz; Sholom Wacholder; Ashlie Feldman; Tina Raine-Bennett; Thomas Lorey; Philip E Castle; Meredith Yeager; Robert D Burk; Lisa Mirabello
Journal:  Papillomavirus Res       Date:  2015-12-01

10.  Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.

Authors:  Wen-Liang Fang; Kuo-Hung Huang; Yuan-Tzu Lan; Chien-Hsing Lin; Shih-Ching Chang; Ming-Huang Chen; Yee Chao; Wen-Chang Lin; Su-Shun Lo; Anna Fen-Yau Li; Chew-Wun Wu; Shih-Hwa Chiou; Yi-Ming Shyr
Journal:  Oncotarget       Date:  2016-02-02
View more
  4 in total

1.  Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.

Authors:  K A Lang Kuhs; D L Faden; L Chen; D K Smith; M Pinheiro; C B Wood; S Davis; M Yeager; J F Boland; M Cullen; M Steinberg; S Bass; X Wang; P Liu; M Mehrad; T Tucker; J S Lewis; R L Ferris; L Mirabello
Journal:  Ann Oncol       Date:  2022-03-16       Impact factor: 51.769

2.  Prospective assessment of multiple HPV-positive oropharyngeal squamous cell carcinomas.

Authors:  Daniel L Faden; Connor J O'Boyle; Derrick T Lin; Daniel G Deschler; Kevin S Emerick; Mark A Varvares; William C Faquin; Peter M Sadow; Jeremy D Richmon
Journal:  Oral Oncol       Date:  2021-02-15       Impact factor: 5.972

3.  APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma.

Authors:  Daniel L Faden; Krystle A Lang Kuhs; Maoxuan Lin; Adam Langenbucher; Maisa Pinheiro; Meredith Yeager; Michael Cullen; Joseph F Boland; Mia Steinberg; Sara Bass; James S Lewis; Michael S Lawrence; Robert L Ferris; Lisa Mirabello
Journal:  Viruses       Date:  2021-08-23       Impact factor: 5.048

4.  Single-cell transcriptomic profiling for inferring tumor origin and mechanisms of therapeutic resistance.

Authors:  Michael S Lawrence; Daniel L Faden; Maoxuan Lin; Moshe Sade-Feldman; Lori Wirth
Journal:  NPJ Precis Oncol       Date:  2022-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.